Related Experiment Video
Updated: Jun 19, 2026
10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Atypical antipsychotics: revolutionary or incremental advance?
1Clinical Research and Evaluation Facility, Nathan S. Kline Institute for Psychiatric Research, 140 Old Orangeburg Road, Orangeburg, NY 10962, USA. citrome@nki.rfmh.org
Expert Review of Neurotherapeutics
|October 9, 2009
Summary
First-generation antipsychotics improved schizophrenia treatment but had limitations. Newer second-generation antipsychotics, including clozapine, offer better efficacy for refractory schizophrenia and other conditions.
Area of Science:
- Psychiatry
- Pharmacology
- Neuroscience
Background:
- First-generation antipsychotics marked a significant advance in schizophrenia treatment.
- These medications were effective for positive symptoms but limited for negative symptoms, cognition, and aggression.
- Clozapine, a second-generation antipsychotic, was developed for treatment-refractory schizophrenia.
Purpose of the Study:
- To review the evolution of antipsychotic treatments for schizophrenia.
- To discuss the limitations of existing treatments and the development of newer agents.
- To explore the potential of atypical antipsychotics for broader applications.
Main Methods:
- Literature review of antipsychotic drug development and clinical applications.
- Analysis of treatment efficacy across different symptom domains of schizophrenia.
- Examination of the role of clozapine and subsequent second-generation antipsychotics.
Main Results:
- First-generation antipsychotics primarily addressed positive symptoms of schizophrenia.
- Second-generation antipsychotics, including clozapine, show improved efficacy for refractory cases.
- Atypical antipsychotics demonstrate potential for mood dysregulation and agitation.
Conclusions:
- The development of antipsychotics has progressed from targeting positive symptoms to addressing broader aspects of schizophrenia.
- Clozapine's efficacy in treatment-refractory schizophrenia paved the way for newer agents.
- Second-generation antipsychotics offer expanded therapeutic possibilities beyond traditional antipsychotic indications.
Related Concept Videos
01:21Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...